Steven J. Romano
CIK 1639860 · EVP and Chief R&D Officer · last filed 2026-05-22
Steven J. Romano is an EVP and Chief R&D Officer who has filed 24 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for DNTH, was dated May 22, 2026. Across all open-market trades the lifetime net is +$234.7K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
24
$234.7K
Holdings By Company
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2026-01-06 | SLN | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2025-01-06 | SLN | Grant (A) | — | $0 | EDGAR |
| 2024-09-18 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | Keenova Therapeutics plc (MNK) Delisted | Disp (D) | −72,637 | $0 | EDGAR |
| 2020-04-03 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −4,946 | -$9.2K | EDGAR |
| 2020-01-07 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −1,167 | -$3.9K | EDGAR |
| 2019-07-03 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −285 | -$2.6K | EDGAR |
| 2019-04-03 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +19,359 | -$70.7K | EDGAR |